İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

MEHLİKA DİLEK ALTINTOP

PROFESÖR

ANADOLU ÜNİVERSİTESİ ECZACILIK FAKÜLTESİ ECZACILIK MESLEK BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Farmasotik Kimya

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 117
  • Proje 0
  • Kitap 15
  • Bildiri 151
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 34 Q2 39 Q3 35 Q4 1
WoS (JCR) Q1 26 Q2 24 Q3 28 Q4 34
TR Index 15 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 25
Ort. yüzdelik 75.1%
Üst %1 payı 0.0%
Üst %10 payı 25.3%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 117 yayın

Scopus (SJR)
Q1 34 Q2 39 Q3 35 Q4 1
WoS (JCR)
Q1 26 Q2 24 Q3 28 Q4 34
TR Index
15 makale

Makale listesi

  1. 2026 Development of a new series of thiazoles as EGFR-targeted anticancer agents for NSCLC therapy through nanotechnological and computer-aided approaches Bioorganic Chemistry DOI 10.1016/j.bioorg.2026.109938 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 98.6%
  2. 2025 Design, synthesis, in vitro and in silico evaluation of thiazole-hydrazone hybrids as potent and safe α-glucosidase inhibitors Bioorganic Chemistry DOI 10.1016/j.bioorg.2025.109257 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 92.6%
  3. 2024 Design, Synthesis, and In Vivo Evaluation of a New Series of Indole-Chalcone Hybrids as Analgesic and Anti-Inflammatory Agents ACS Omega DOI 10.1021/acsomega.4c00026 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 98.7%
  4. 2024 Design, Synthesis, and Evaluation of New Pyrazolines As Small Molecule Inhibitors of Acetylcholinesterase ACS Omega DOI 10.1021/acsomega.3c10490 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 90.4%
  5. 2024 Boswellia sp. oleogum resins: high-performance thin-layer chromatography‒effect-directed pancreatic lipase inhibition profiles and molecular docking studies JPC – Journal of Planar Chromatography – Modern TLC DOI 10.1007/s00764-025-00331-5 YÖKSİS SJR Q3 JCR Q4 OpenAlex 22.6%
  6. 2024 Design, synthesis and biological evaluation of a new series of imidazothiazole-hydrazone hybrids as dual EGFR and Akt inhibitors for NSCLC therapy European Journal of Medicinal Chemistry DOI 10.1016/j.ejmech.2024.116698 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 97.2%
  7. 2023 A new series of thiazole‐hydrazone hybrids for Akt‐targeted therapy of non‐small cell lung cancer DRUG DEVELOPMENT RESEARCH DOI 10.1002/ddr.22022 YÖKSİS SJR Q2 JCR Q2 OpenAlex 85.5%
  8. 2023 Microwave-assisted synthesis of a series of 4,5-dihydro-1H-pyrazoles endowed with selective COX-1 inhibitory potency JOURNAL OF THE SERBIAN CHEMICAL SOCIETY DOI 10.2298/JSC220907001A YÖKSİS SJR Q3 JCR Q4 OpenAlex 74.8%
  9. 2023 Design, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy ACS Omega DOI 10.1021/acsomega.3c02331 YÖKSİS SJR Q2 JCR Q2 OpenAlex 74.1%
  10. 2023 Synthesis, in silico and in vitro evaluation of new 3,5-disubstituted-1,2,4-oxadiazole derivatives as carbonic anhydrase inhibitors and cytotoxic agents Journal of Molecular Structure DOI 10.1016/j.molstruc.2022.134699 YÖKSİS SJR Q2 JCR Q2 OpenAlex 66.9%
  11. 2023 Discovery of Small Molecule COX-1 and Akt Inhibitors as Anti-NSCLC Agents Endowed with Anti-Inflammatory Action INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES DOI 10.3390/ijms24032648 YÖKSİS SJR Q1 JCR Q1 OpenAlex 81.1%
  12. 2023 In vitro evaluation of 2-pyrazoline derivatives as DPP-4 inhibitors Turkish Journal of Biochemistry-Turk Biyokimya Dergisi DOI 10.1515/tjb-2022-0161 YÖKSİS SJR Q3 JCR Q4 OpenAlex 60.1%
  13. 2023 A new series of hydrazones as small‐molecule aldose reductase inhibitors ARCHIV DER PHARMAZIE DOI 10.1002/ardp.202200570 YÖKSİS SJR Q2 JCR Q1 OpenAlex üst %10 OpenAlex 90.7%
  14. 2023 Design, Synthesis, and Evaluation of a New Series of 2-Pyrazolines as Potential Antileukemic Agents ACS Omega DOI 10.1021/acsomega.3c05860 YÖKSİS SJR Q2 JCR Q2 OpenAlex 72.8%
  15. 2022 A new series of thiosemicarbazone‐based anti‐inflammatory agents exerting their action through cyclooxygenase inhibition Archiv der Pharmazie DOI 10.1002/ardp.202200136 YÖKSİS SJR Q2 JCR Q1 OpenAlex 75.6%
  16. 2022 A New Series of Indeno[1,2-c]pyrazoles as EGFR TK Inhibitors for NSCLC Therapy Molecules DOI 10.3390/molecules27020485 YÖKSİS SJR Q1 JCR Q2 OpenAlex 80.8%
  17. 2022 Design, synthesis and biological evaluation of a new series of arylidene indanones as small molecules for targeted therapy of non-small cell lung carcinoma and prostate cancer European Journal of Medicinal Chemistry DOI 10.1016/j.ejmech.2022.114851 YÖKSİS SJR Q1 JCR Q1 OpenAlex 70.9%
  18. 2021 Synthesis of New Bis-pyrazolines Endowed with Potent Antifungal Activity against Candida albicans and Aspergillus niger Letters in Drug Design Discovery YÖKSİS SJR Q3 JCR Q4
  19. 2021 A new series of benzoxazole-based SIRT1 modulators for targeted therapy of non-small-cell lung cancer Archiv der Pharmazie DOI 10.1002/ardp.202000235 YÖKSİS SJR Q2 JCR Q2 OpenAlex 71.0%
  20. 2021 An extensive research on aldose reductase inhibitory effects of new 4H-1,2,4-triazole derivatives Journal of Molecular Structure DOI 10.1016/j.molstruc.2020.129446 YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 94.7%

Akademisyenlere dön